Whereas targeting the p40 (14, 15) as well as the p19 (16) subunit of IL-23 reduced clinical and histological inflammation in human Crohn’s disease, targeting IL-17A (17) or IL-17RA (18) was ineffective or even deleterious, respectively. The gene discussed is IL23A; the disease is Crohn disease.